BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18411255)

  • 1. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.
    Kyratzi E; Pavlaki M; Stefanis L
    Hum Mol Genet; 2008 Jul; 17(14):2160-71. PubMed ID: 18411255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
    Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L
    Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population.
    Xue S; Jia J
    Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.
    Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D
    Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy.
    Kabuta T; Wada K
    Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
    Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1.
    Tse HS; Hu HY; Sze KH
    Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCH-L1 S18Y variant and risk of Parkinson's disease in Asian populations: an updated meta-analysis.
    Zhu R; Zhu Y; Liu X; He Z
    Neurodegener Dis; 2014; 14(4):194-203. PubMed ID: 25471998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.
    Mellick GD; Silburn PA
    Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron.
    Osaka H; Wang YL; Takada K; Takizawa S; Setsuie R; Li H; Sato Y; Nishikawa K; Sun YJ; Sakurai M; Harada T; Hara Y; Kimura I; Chiba S; Namikawa K; Kiyama H; Noda M; Aoki S; Wada K
    Hum Mol Genet; 2003 Aug; 12(16):1945-58. PubMed ID: 12913066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
    Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
    Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
    Cartier AE; Ubhi K; Spencer B; Vazquez-Roque RA; Kosberg KA; Fourgeaud L; Kanayson P; Patrick C; Rockenstein E; Patrick GN; Masliah E
    PLoS One; 2012; 7(4):e34713. PubMed ID: 22514658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
    Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
    Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson's disease in the Chinese population.
    Wang L; Guo JF; Nie LL; Luo L; Zuo X; Shen L; Jiang H; Yan XX; Xia K; Pan Q; Tang BS
    J Clin Neurosci; 2011 Apr; 18(4):541-4. PubMed ID: 21315600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.
    Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH
    Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.
    Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K
    Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity.
    Walters BJ; Campbell SL; Chen PC; Taylor AP; Schroeder DG; Dobrunz LE; Artavanis-Tsakonas K; Ploegh HL; Wilson JA; Cox GA; Wilson SM
    Mol Cell Neurosci; 2008 Dec; 39(4):539-48. PubMed ID: 18771733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
    Lee YC; Hsu SD
    Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents.
    Galter D; Westerlund M; Belin AC; Olson L
    Physiol Behav; 2007 Sep; 92(1-2):46-53. PubMed ID: 17599367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.